Product correctly added to cart.

discount label
1-Boc-3-iodoazetidine
View 3D

Biosynth logo

1-Boc-3-iodoazetidine

CAS: 254454-54-1

Ref. 3D-FB138678

5gTo inquire
10gTo inquire
25gTo inquire
50gTo inquire
100gTo inquire
Estimated delivery in United States, on Tuesday 11 Feb 2025

Product Information

Name:
1-Boc-3-iodoazetidine
Synonyms:
  • N-Boc-3-iodoazetidine
  • 1-tert-Butoxycarbonyl-3-iodoazetidine
  • Tert-Butyl 3-Iodoazetidine-1-Carboxylate
  • 1-Boc-3-(iodo)azetidine
Description:

1-Boc-3-iodoazetidine (1BIA) is an organometallic compound that was synthesized using a cross-coupling reaction. 1BIA has shown to be a covalent inhibitor of the enzyme lysine residues, which are involved in protein synthesis. It has been shown to be effective against cancer cells in cell culture studies. The pharmacokinetics of 1BIA have been studied in rats and mice. Oral administration showed bioavailability of about 50% and plasma clearance of about 0.4 ml/min/kg, suggesting that it may be used for cancer therapy.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
283.11 g/mol
Formula:
C8H14INO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FB138678 1-Boc-3-iodoazetidine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".